Schedule 13G ownership disclosure
Neumora Therapeutics Inc
Common Stock par value $0.0001 per share · CUSIP: 640979100
Event date: 2024-12-31
- Filing-level shares
- 8,226,272
- Percent of class
- 5.1%
- Paul L Berns
Shares: 8,226,272 · Class: 5.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-019939
- Form type
- SCHEDULE 13G/A
- Filer
- BERNS PAUL L
- CIK
- CIK 1202769
- Filed
- Feb 13, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership